- Home
- /Lithium
Lithium
Measures lithium levels in serum or plasma to assess medication dosing and kidney function.
Why This Biomarker Matters
Proper lithium monitoring ensures therapeutic effectiveness while preventing toxicity; regular testing protects kidney health in patients on long-term lithium therapy.
Overview
This test measures lithium levels in urine to assess medication compliance and kidney function in patients taking lithium for bipolar disorder or severe depression. Lithium is a mood-stabilizing medication with a narrow therapeutic window—too low and it's ineffective, too high and it's toxic. Urine lithium monitoring helps ensure adequate dosing while avoiding toxicity. Chronic lithium use can affect kidney function, so periodic urine and blood testing is important. Your healthcare provider uses these results to optimize your dose and monitor for side effects.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
3719-2Primary14334-73721-83720-09358-325462-325463-125461-54300-0101751-69815-217086-018238-618477-034330-13718-443176-750872-156032-6Available Lab Tests
Order tests that measure this biomarker